LeMaitre Vascular Inc (LMAT) stock
LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3022% below fair value
$76.10−0.91 (-1.18%)
Close on Nov 17, 2026Market cap $1.74BP/E 26.7Yield 1.05%
LeMaitre Vascular total assets
Total assets on the balance sheet at the end of each period.
LeMaitre Vascular's total assets was $640.55M at Jun 30, 2026. For fiscal 2025 it was $615.69M, up 11.6% from the year before. Over ten years it grew 21.1% a year on average. The highest annual figure on record is $615.69M in fiscal 2025.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $615.69M | +11.6% |
| FY2024 | Dec 31, 2024 | $551.82M | +59.1% |
| FY2023 | Dec 31, 2023 | $346.78M | +11.7% |
| FY2022 | Dec 31, 2022 | $310.48M | +6.0% |
| FY2021 | Dec 31, 2021 | $292.80M | +15.8% |
| FY2020 | Dec 31, 2020 | $252.81M | +34.2% |
| FY2019 | Dec 31, 2019 | $188.34M | +23.0% |
| FY2018 | Dec 31, 2018 | $153.09M | +21.2% |
| FY2017 | Dec 31, 2017 | $126.32M | +23.9% |
| FY2016 | Dec 31, 2016 | $101.92M | +12.4% |
| FY2015 | Dec 31, 2015 | $90.70M | +11.3% |
| FY2014 | Dec 31, 2014 | $81.49M | +15.6% |
| FY2013 | Dec 31, 2013 | $70.49M | +11.8% |
| FY2012 | Dec 31, 2012 | $63.06M | +5.7% |
| FY2011 | Dec 31, 2011 | $59.69M | -5.7% |
| FY2010 | Dec 31, 2010 | $63.27M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $640.55M | +10.9% |
| Q1 FY2026 | Mar 31, 2026 | $629.53M | +13.2% |
| Q4 FY2025 | Dec 31, 2025 | $615.69M | +11.6% |
| Q3 FY2025 | Sep 30, 2025 | $598.07M | +58.6% |
| Q2 FY2025 | Jun 30, 2025 | $577.59M | +59.1% |
| Q1 FY2025 | Mar 31, 2025 | $556.01M | +57.1% |
| Q4 FY2024 | Dec 31, 2024 | $551.82M | +59.1% |
| Q3 FY2024 | Sep 30, 2024 | $377.03M | +12.9% |
| Q2 FY2024 | Jun 30, 2024 | $363.08M | +11.2% |
| Q1 FY2024 | Mar 31, 2024 | $353.96M | +12.4% |
| Q4 FY2023 | Dec 31, 2023 | $346.78M | +11.7% |
| Q3 FY2023 | Sep 30, 2023 | $334.01M | +10.6% |
| Q2 FY2023 | Jun 30, 2023 | $326.47M | +9.0% |
| Q1 FY2023 | Mar 31, 2023 | $314.87M | +7.7% |
| Q4 FY2022 | Dec 31, 2022 | $310.48M | +6.0% |
| Q3 FY2022 | Sep 30, 2022 | $302.05M | +4.3% |
| Q2 FY2022 | Jun 30, 2022 | $299.43M | +21.5% |
| Q1 FY2022 | Mar 31, 2022 | $292.45M | +18.2% |
| Q4 FY2021 | Dec 31, 2021 | $292.80M | +15.8% |
| Q3 FY2021 | Sep 30, 2021 | $289.47M | +10.7% |
| Q2 FY2021 | Jun 30, 2021 | $246.51M | -3.6% |
| Q1 FY2021 | Mar 31, 2021 | $247.37M | +34.0% |
| Q4 FY2020 | Dec 31, 2020 | $252.81M | +34.2% |
| Q3 FY2020 | Sep 30, 2020 | $261.57M | +53.9% |
| Q2 FY2020 | Jun 30, 2020 | $255.72M | +57.2% |
| Q1 FY2020 | Mar 31, 2020 | $184.56M | +15.2% |
| Q4 FY2019 | Dec 31, 2019 | $188.34M | +23.0% |
| Q3 FY2019 | Sep 30, 2019 | $170.01M | +17.8% |
| Q2 FY2019 | Jun 30, 2019 | $162.66M | +18.6% |
| Q1 FY2019 | Mar 31, 2019 | $160.25M | +23.8% |
| Q4 FY2018 | Dec 31, 2018 | $153.09M | +21.2% |
| Q3 FY2018 | Sep 30, 2018 | $144.33M | +19.0% |
| Q2 FY2018 | Jun 30, 2018 | $137.10M | +22.4% |
| Q1 FY2018 | Mar 31, 2018 | $129.41M | +21.5% |
| Q4 FY2017 | Dec 31, 2017 | $126.32M | +23.9% |
| Q3 FY2017 | Sep 30, 2017 | $121.27M | +19.7% |
| Q2 FY2017 | Jun 30, 2017 | $112.05M | – |
| Q1 FY2017 | Mar 31, 2017 | $106.52M | – |
| Q4 FY2016 | Dec 31, 2016 | $101.92M | – |
| Q3 FY2016 | Sep 30, 2016 | $101.31M | – |
See a number that looks wrong?